|Register a trial||Search ISRCTN|
Dear Dr CERASALE MORTEO,
An increasing number of medical journals, including BMC Hematology, require registration of clinical trials before publication of a protocol and/or trial result.
Registration is the first step towards trial transparency and the future dissemination of health research outcomes, of which BioMed Central is a strong advocate. The ISRCTN registry, administered by BioMed Central, is a direct result of this commitment.
|Why register your trial in ISRCTN?|
|Simple and flexible submission process – contextual help, save function, integration of the ORCID identifier. Follow up messages enable you to stay updated with the progress of your registration.|
|Browse categories at a glance and search by condition, intervention, funder and many other fields.|
|Content is reviewed and curated by a team of expert editors.|
|Prospective and retrospective registrations accepted.|
|New fields, such as recruitment start and end dates and participating sites, allow prospective participants to find relevant studies.|
|High visibility – Content freely, publicly accessible and deposited in the international WHO trial search portal and in the UK Clinical Trials Gateway, if recruiting in the UK.|
The preferred partner of the Department of Health (UK)
Try it yourself, register your trial with an ISRCTN today!
|Registered studies include|
Access more trials on hematological disorders here.
|About the registry|
The ISRCTN registry is a primary clinical trial registry recognised by WHO and ICMJE that accepts all clinical research studies (whether proposed, ongoing or completed), providing content validation and curation and the unique identification number necessary for publication. All study records in the database are freely accessible and searchable.